IBDEI11T ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18486,1,4,0)
 ;;=4^MAL NEO KIDNEY
 ;;^UTILITY(U,$J,358.3,18486,1,5,0)
 ;;=5^189.0
 ;;^UTILITY(U,$J,358.3,18486,2)
 ;;=^73523
 ;;^UTILITY(U,$J,358.3,18487,0)
 ;;=580.4^^102^1188^20
 ;;^UTILITY(U,$J,358.3,18487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18487,1,4,0)
 ;;=4^NEPHRIT AC REAPIDLY PROGR
 ;;^UTILITY(U,$J,358.3,18487,1,5,0)
 ;;=5^580.4
 ;;^UTILITY(U,$J,358.3,18487,2)
 ;;=^270339
 ;;^UTILITY(U,$J,358.3,18488,0)
 ;;=580.81^^102^1188^21
 ;;^UTILITY(U,$J,358.3,18488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18488,1,4,0)
 ;;=4^NEPHRITIS AC IN OTH DIS
 ;;^UTILITY(U,$J,358.3,18488,1,5,0)
 ;;=5^580.81
 ;;^UTILITY(U,$J,358.3,18488,2)
 ;;=^270341
 ;;^UTILITY(U,$J,358.3,18489,0)
 ;;=580.89^^102^1188^22
 ;;^UTILITY(U,$J,358.3,18489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18489,1,4,0)
 ;;=4^NEPHRITIS AC NEC
 ;;^UTILITY(U,$J,358.3,18489,1,5,0)
 ;;=5^580.89
 ;;^UTILITY(U,$J,358.3,18489,2)
 ;;=^270340
 ;;^UTILITY(U,$J,358.3,18490,0)
 ;;=580.9^^102^1188^23
 ;;^UTILITY(U,$J,358.3,18490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18490,1,4,0)
 ;;=4^NEPHRITIS AC NOS
 ;;^UTILITY(U,$J,358.3,18490,1,5,0)
 ;;=5^580.9
 ;;^UTILITY(U,$J,358.3,18490,2)
 ;;=^270342
 ;;^UTILITY(U,$J,358.3,18491,0)
 ;;=580.0^^102^1188^24
 ;;^UTILITY(U,$J,358.3,18491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18491,1,4,0)
 ;;=4^NEPHRITIS AC PROLIFERAT
 ;;^UTILITY(U,$J,358.3,18491,1,5,0)
 ;;=5^580.0
 ;;^UTILITY(U,$J,358.3,18491,2)
 ;;=^270338
 ;;^UTILITY(U,$J,358.3,18492,0)
 ;;=582.0^^102^1188^25
 ;;^UTILITY(U,$J,358.3,18492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18492,1,4,0)
 ;;=4^NEPHRITIS CHR PROLIFERAT
 ;;^UTILITY(U,$J,358.3,18492,1,5,0)
 ;;=5^582.0
 ;;^UTILITY(U,$J,358.3,18492,2)
 ;;=^270347
 ;;^UTILITY(U,$J,358.3,18493,0)
 ;;=586.^^102^1188^26
 ;;^UTILITY(U,$J,358.3,18493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18493,1,4,0)
 ;;=4^RENAL FAILURE NOS
 ;;^UTILITY(U,$J,358.3,18493,1,5,0)
 ;;=5^586.
 ;;^UTILITY(U,$J,358.3,18493,2)
 ;;=^104733
 ;;^UTILITY(U,$J,358.3,18494,0)
 ;;=593.81^^102^1188^27
 ;;^UTILITY(U,$J,358.3,18494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18494,1,4,0)
 ;;=4^RENAL VASCULAR DISORDER
 ;;^UTILITY(U,$J,358.3,18494,1,5,0)
 ;;=5^593.81
 ;;^UTILITY(U,$J,358.3,18494,2)
 ;;=^270382
 ;;^UTILITY(U,$J,358.3,18495,0)
 ;;=198.0^^102^1188^2
 ;;^UTILITY(U,$J,358.3,18495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18495,1,4,0)
 ;;=4^CA MET NEO KIDNEY
 ;;^UTILITY(U,$J,358.3,18495,1,5,0)
 ;;=5^198.0
 ;;^UTILITY(U,$J,358.3,18495,2)
 ;;=^267331
 ;;^UTILITY(U,$J,358.3,18496,0)
 ;;=571.8^^102^1189^1
 ;;^UTILITY(U,$J,358.3,18496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18496,1,4,0)
 ;;=4^CHRONIC LIVER DIS NEC
 ;;^UTILITY(U,$J,358.3,18496,1,5,0)
 ;;=5^571.8
 ;;^UTILITY(U,$J,358.3,18496,2)
 ;;=^87404
 ;;^UTILITY(U,$J,358.3,18497,0)
 ;;=571.5^^102^1189^2
 ;;^UTILITY(U,$J,358.3,18497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18497,1,4,0)
 ;;=4^CIRRHOSIS OF LIVER NOS
 ;;^UTILITY(U,$J,358.3,18497,1,5,0)
 ;;=5^571.5
 ;;^UTILITY(U,$J,358.3,18497,2)
 ;;=^24731
 ;;^UTILITY(U,$J,358.3,18498,0)
 ;;=070.54^^102^1189^3
 ;;^UTILITY(U,$J,358.3,18498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18498,1,4,0)
 ;;=4^HEP C CHR W/O COMA
 ;;^UTILITY(U,$J,358.3,18498,1,5,0)
 ;;=5^070.54
 ;;^UTILITY(U,$J,358.3,18498,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,18499,0)
 ;;=070.44^^102^1189^4
 ;;^UTILITY(U,$J,358.3,18499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18499,1,4,0)
 ;;=4^HEP C CHR W/ COMA
 ;;^UTILITY(U,$J,358.3,18499,1,5,0)
 ;;=5^070.44
 ;;^UTILITY(U,$J,358.3,18499,2)
 ;;=^303251
 ;;^UTILITY(U,$J,358.3,18500,0)
 ;;=070.41^^102^1189^5
 ;;
 ;;$END ROU IBDEI11T
